Hologic shares gain on authorization of COVID-19 test for asymptomatic people

/ / News

Shares of Hologic Inc. were up 3.6% in premarket trading on Monday after the company said it had received emergency use authorization from the Food and Drug Administration for a diagnostic test specifically aimed at people with asymptomatic COVID-19 infections. Hologic said it is the first company to offer a test screening asymptomatic individuals. This test, which is also authorized to test symptomatic people for COVID-19 infections, originally received authorization in March. Hologic’s stock is up 23.2% this year, while the S&P 500 has gained 2.1%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.